Redhill Biopharma - ADR

NASDAQ:RDHL   3:59:58 PM EDT
6.95
-0.01 (-0.14%)
Earnings Announcements

Redhill Biopharma Reports Q1 Net Revenues of ~$20.6 mln

Published: 05/27/2021 11:44 GMT
Redhill Biopharma - ADR (RDHL) - Redhill Biopharma Reports First Quarter 2021 Financial Results and Operational Highlights.
Redhill Biopharma Ltd - Q1/2021 Net Revenues of Approximately $20.6 Million Compared to $1.1 Million.
Revenue is expected to be $25.02 Million
Adjusted EPS is expected to be -$0.30

Next Quarter Revenue Guidance is expected to be $30.78 Million
Next Quarter EPS Guidance is expected to be -$0.24

More details on our Analysts Page.